目前的药物代谢 SCISCIE

期刊简介预计审稿时间：偏慢,4-8周

Current Drug Metabolism aims to cover all the latest and outstanding developments in drug metabolism, pharmacokinetics, and drug disposition. The journal serves as an international forum for the publication of full-length/mini review, research articles and guest edited issues in drug metabolism. Current Drug Metabolism is an essential journal for academic, clinical, government and pharmaceutical scientists who wish to be kept informed and up-to-date with the most important developments. The journal covers the following general topic areas: pharmaceutics, pharmacokinetics, toxicology, and most importantly drug metabolism.

More specifically, in vitro and in vivo drug metabolism of phase I and phase II enzymes or metabolic pathways; drug-drug interactions and enzyme kinetics; pharmacokinetics, pharmacokinetic-pharmacodynamic modeling, and toxicokinetics; interspecies differences in metabolism or pharmacokinetics, species scaling and extrapolations; drug transporters; target organ toxicity and interindividual variability in drug exposure-response; extrahepatic metabolism; bioactivation, reactive metabolites, and developments for the identification of drug metabolites. Preclinical and clinical reviews describing the drug metabolism and pharmacokinetics of marketed drugs or drug classes.

Current Drug Metabolism 旨在涵盖药物代谢、药代动力学和药物处置方面的所有最新和杰出的发展。该杂志是发表药物代谢方面的完整/迷你评论、研究文章和客座编辑问题的国际论坛。 Current Drug Metabolism 是学术、临床、政府和制药科学家的重要期刊，他们希望随时了解和了解最重要的发展。该杂志涵盖以下一般主题领域：药剂学、药代动力学、毒理学，以及最重要的药物代谢。

更具体地说，I期和II期酶或代谢途径的体外和体内药物代谢；药物-药物相互作用和酶动力学；药代动力学、药代动力学-药效学模型和毒代动力学；代谢或药代动力学、物种缩放和外推的种间差异；药物转运体；靶器官毒性和药物暴露反应的个体差异；肝外代谢；生物活化、反应性代谢物和药物代谢物鉴定的发展。描述已上市药物或药物类别的药物代谢和药代动力学的临床前和临床综述。

《Current Drug Metabolism》(目前的药物代谢)编辑部通讯方式为BENTHAM SCIENCE PUBL LTD, EXECUTIVE STE Y26, PO BOX 7917, SAIF ZONE, SHARJAH, U ARAB EMIRATES, 1200 BR。如果您需要协助投稿或润稿服务，您可以咨询我们的客服老师。我们专注于期刊投稿服务十年，熟悉发表政策，可为您提供一对一投稿指导，避免您在投稿时频繁碰壁，节省您的宝贵时间，有效提升发表机率，确保SCI检索（检索不了全额退款）。我们视信誉为生命，多方面确保文章安全保密，在任何情况下都不会泄露您的个人信息或稿件内容。